AACAP has long been a leader in managing disclosures and potential conflicts of interest that can and do interfere with objective conduct of science and clinical practice. It has long been important to AACAP and the Program Committee, as we develop and present our meetings, to keep content and presentations independent from sources of funding or other support. For more than 11 years, AACAP has managed its meetings under the Operating Principles for Extramural Support. The Operating Principles represent a dynamic process designed to serve our patients and profession, and maintain our scientific and clinical integrity. As a result, your awareness and participation are essential to their success. We hope you will take pride in our Principles and your participation in the process. For your reference, the full document can be read here.
While the Operating Principles is an extensive document that covers many details related to the Annual Meeting, some of the most critical points are:
- Commercial enterprises (including pharmaceutical companies) and other entities related to AACAP’s Annual Meeting, agree to not have independent presentations during the week of the Annual Meeting at the host hotel or elsewhere in the meeting city.
- No corporate logos may be displayed outside the Exhibit Hall.
- No press conferences or briefings may be held prior to presentations at AACAP meetings nor can sponsors represent AACAP meeting content without specific written permission from AACAP.
- Companies may not contact attendees before the meeting to promote attendance at sponsored events.
How You Can Help As an Attendee
- If you know about an event held by a pharmaceutical company during the week of the Annual Meeting that is not listed in the Program Book, please contact Jill Brafford, Director of Meetings and Continuing Medical Education, at 202.966.7719 or via email.
- Let AACAP know if the following disclosure policies are not being adhered to:
- All individuals presenting at AACAP meetings (including presenters, officers, discussants, etc.) must disclose any real or perceived conflicts of interest. This obligation is for all individuals who make public comment at any AACAP meeting
- When an off-label, investigational or experimental use of a medication or other product is the subject of a presentation or discussion, disclosure of this status should be clear to the audience, both verbally and in writing.
- Contact the session Monitor and note these on your evaluation forms.